-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...
More »SEARCH RESULT
Medicines should be within reach of common man: SC
-IANS Protecting the interest of the common man, the Supreme Court Wednesday told the government not to disturb the existing retail price mechanism of drugs under the price control order while finalising the list of essential medicines. The judges observed that the prices of the drugs were so high that it left the patient with the option of either to die or buy medicines by selling one's land or ornaments. "The common man...
More »Midnight’s children-Purnima S Tripathi
-Frontline Members of denotified, nomadic and semi-nomadic tribes, treated as criminal tribes by the colonial rulers, have no place to call their own and no land, no rights, and no support from the government. Emaciated, eyes sunken deep into sockets, skin hanging loose, almost gasping for breath, Indro Devi and Sarvnath, a couple in their eighties, lie on polythene sheets in an 8×10 square-foot tent made of rags, by a stinking nullah...
More »India Coaxes Tribal Girls Into Schools -Manipadma Jena
-IPS News RAYAGADA- The deafening din of the lunch gong is sweet music to the 200-odd tribal girls rushing down the stairway, clutching stainless steel plates and tumblers. Sikhsya Niketan (House of Education) in Chattikona administrative block of Rayagada district is a residential school meant exclusively for girls of the Dongria Kondh tribe in eastern Odisha state. The school is part of the federal government’s intensified efforts to take universal education to...
More »Novartis subsidy promise with rider
-The Telegraph Swiss pharma company Novartis today told the Supreme Court that if it gets an Indian patent on its anti-cancer drug Glivec, it would continue giving free drugs to 85 per cent patients till 2018 provided prices were left untouched. But the court described its scheme of classifying people on the basis of their incomes as “too complicated” and again urged the company to reduce prices. Whatever the scheme, the end result...
More »